Coronary thrombolysis: round two and beyond
Open Access
- 1 April 1991
- Vol. 65 (4) , 175-176
- https://doi.org/10.1136/hrt.65.4.175
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- EFFECTS OF ALTEPLASE IN ACUTE MYOCARDIAL-INFARCTION - 6-MONTH RESULTS FROM THE ASSET STUDY1990
- Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulationThe Lancet, 1990
- Antistreptokinase titres after intravenous streptokinaseThe Lancet, 1990
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- An objective study of alternative methods of heparin administrationThrombosis Research, 1980